ESTRO 2024 - Abstract Book

S1173

Clinical - Haematology

ESTRO 2024

underwent the procedure comfortably without interruption, with 95.56% successful engraftment and 75.56% in remission till date. Patients had grade 2-3 mucositis, grade 1-2enteritis, nausea and fatigue, while 2 had Grade 4 mucositis. No patient had radiation pneumonitis.

Conclusion:

Helical Tomotherapy® provides a comprehensive and convenient solution for TBI . The treatment planning and implementation can be appropriately tailored to patient’s physical parameters and conditioning regimen. Well conformed plans with adequate coverage and acceptable toxicities can be achieved on Helical Tomotherapy.

Keywords: TBI, Tomotherapy

References:

Cleuziou, J.P. & Desgranges, C. & Henry, I. & Jaumot, M. & Chartier, P. & Sihanath, R. & Carré, M. & Bulabois, C.E. & Cahn, Jean-Yves & Pasteris, C. & Balosso, Jacques & gabelle-flandin, Isabelle & Verry, Camille & Giraud, Jean-Yves. (2021). Total body irradiation using helical tomotherapy: Set-up experience and in-vivo dosimetric evaluation. Cancer/Radiothérapie. 25. 10.1016/j.canrad.2020.07.009.

2926

Poster Discussion

Blood tumor burden and quality of life improvement in Sézary syndrome treated with radiotherapy

Khaled Elsayad, Christian Kandler, Niklas Benedikt Pepper, Jan Jakob Siats, Hans Theodor Eich

University Hospital Munster, Radiation Oncology, Münster, Germany

Purpose/Objective:

Erythrodermic mycosis fungoides (MF) and Sézary-syndrome (SS) patients suffer from severe health-related quality of life (HRQoL) impairment. Limited radiotherapy trials include erythrodermic MF and SS with few long-term remissions. In this analysis, we aimed to assess the efficacy of total skin electron beam therapy (TSEBT) in patients with erythrodermic mycosis fungoides (MF) or Sézary syndrome (SS).

Material/Methods: